SAR113945

DRUG4 trials

Sponsors

Sanofi

Conditions

Knee OsteoarthritisOsteoarthritis

Phase 1

Safety, Tolerability and Pharmacokinetics of SAR113945 Following Intra-articular Administration in Patients With Knee Osteoarthritis

CompletedNCT01113333

SanofiOsteoarthritis

Start: 2010-04-30End: 2011-02-28Target: 40Updated: 2011-03-23

Safety of Single Doses of SAR113945 and Efficacy and Safety of a New Formulation Given Into the Knee in Osteoarthritis Patients / Part I

CompletedNCT01463488

SanofiKnee Osteoarthritis

Start: 2011-11-30End: 2012-08-31Updated: 2012-08-23

Safety, Tolerability and Pharmacokinetics of SAR113945 in Japanese Patients With Knee Osteoarthritis

CompletedNCT01511549

SanofiKnee Osteoarthritis

Start: 2012-01-31End: 2012-09-30Updated: 2012-10-01

Phase 2

Safety of Single Doses of SAR113945 and Efficacy and Safety of a New Formulation Given Into the Knee in Osteoarthritis Patients / Part II

CompletedNCT01598415

SanofiKnee Osteoarthritis

Start: 2012-04-30End: 2013-02-28Updated: 2014-10-17